Rxsight Stock Today
| RXST Stock | USD 7.38 0.10 1.37% |
PerformanceVery Weak
| Odds Of DistressLow
|
Rxsight is selling for under 7.38 as of the 19th of July 2025; that is 1.37 percent increase since the beginning of the trading day. The stock's last reported lowest price was 7.21. Rxsight has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. The company has 40.64 M outstanding shares of which 5.79 M shares are at this time shorted by private and institutional investors with about 5.96 trading days to cover. More on Rxsight
Moving against Rxsight Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Rxsight Stock Highlights
| CEO CoPresident | Ronald MD |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
Rxsight (RXST) is traded on NASDAQ Exchange in USA. It is located in 100 Columbia, Aliso Viejo, CA, United States, 92656 and employs 498 people. Rxsight is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 299.9 M. Rxsight conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 40.64 M outstanding shares of which 5.79 M shares are at this time shorted by private and institutional investors with about 5.96 trading days to cover.
Rxsight currently holds about 128.62 M in cash with (16.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65.
Check Rxsight Probability Of Bankruptcy
Ownership AllocationRxsight owns a total of 40.64 Million outstanding shares. The majority of Rxsight outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rxsight to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rxsight. Please pay attention to any change in the institutional holdings of Rxsight as this could imply that something significant has changed or is about to change at the company. Also note that almost twenty-four thousand three hundred eighty-two invesors are currently shorting Rxsight expressing very little confidence in its future performance.
Check Rxsight Ownership Details
Rxsight Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Rxsight market risk premium is the additional return an investor will receive from holding Rxsight long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.99) | |||
| Total Risk Alpha | (1.71) | |||
| Treynor Ratio | (0.72) |
Rxsight Stock Against Markets
Rxsight Corporate Management
| Matt Haller | Chief Officer | Profile | |
| Alex Huang | Investor Relations | Profile | |
| Oliver Moravcevic | Vice Relations | Profile | |
| Patrick Cullen | Executive Operations | Profile | |
| Scott Gaines | Executive Operations | Profile | |
| Glebb Popov | Vice Accounting | Profile |
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.